Comprehensive genomic characterization of head and neck squamous cell carcinomas. Cancer Genome Atlas Network (2015) Nature 517: 576-82 A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma. Galloway TJ, Wirth LJ, Colevas AD, Gilbert J, Bauman JE, Saba NF, Raben D, Mehra R, Ma AW, Atoyan R, Wang J, Burtness B, Jimeno A (2015) Clin Cancer Res 21: 1566-73 Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T, Volinia S, Croce CM (2014) Oncogene 33: 702-12 Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through β1 integrin, Src and ERK 1/2. Siqueira AS, Pinto MP, Cruz MC, Smuczek B, Cruz KS, Barbuto JA, Hoshino D, Weaver AM, Freitas VM, Jaeger RG (2016) Oncotarget 7: 47904-47917 Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy. Vlacich G, Diaz R, Thorpe SW, Murphy BA, Kirby W, Sinard RJ, Shakhtour B, Shyr Y, Murphy P, Netterville JL, Yarbrough WG, Cmelak AJ (2012) Oncologist 17: 673-81 Optical metabolic imaging of treatment response in human head and neck squamous cell carcinoma. Shah AT, Demory Beckler M, Walsh AJ, Jones WP, Pohlmann PR, Skala MC (2014) PLoS One 9: e90746 Nutrient-based dietary patterns of head and neck squamous cell cancer: a factor analysis in Uruguay. Deneo-Pellegrini H, Boffetta P, De Stefani E, Correa P, Ronco AL, Acosta G, Mendilaharsu M, Silva C, Luaces ME (2013) Cancer Causes Control 24: 1167-74 Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group. Gilbert J, Lee JW, Argiris A, Haigentz M, Feldman LE, Jang M, Arun P, Van Waes C, Forastiere AA (2013) Head Neck 35: 942-8 Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma. Husain H, Psyrri A, Markovic A, Rampias T, Pectasides E, Wang H, Slebos R, Yarbrough WG, Burtness B, Chung CH (2012) Laryngoscope 122: 2762-8 Viable biobanking of primary head and neck squamous cell carcinoma. Godoy JM, Sewell A, Johnston B, Brown BT, Lu X, Sinard RJ, Rohde S, Mannion K, Netterville JL, Yarbrough WG (2013) Laryngoscope 123: 641-5
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.